Identification of nontuberculous mycobacteria using the GenoType CMdirect and GenoType Mycobacterium CM line probe assays in GeneXpert MTB/RIF Ultra negative sputum: A South African prevalence study

•Prevalence of nontuberculous mycobacteria (NTM) among a GXP-negative cohort was 1.7 %.•CMdirect line probe assay showed a specificity of 100 % as a possible rule-in test.•Culture-independent molecular techniques on decontaminated sputum could aid in NTM identification. The GenoType CMdirect Ver 1.0...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diagnostic microbiology and infectious disease 2024-12, Vol.110 (4), p.116531, Article 116531
Hauptverfasser: Opperman, Christoffel, Johannes, Chaldene, Singh, Sarishna, Ghebrekristos, Yonas, Warren, Rob, Esmail, Aliasgar, Goosen, Wynand
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 116531
container_title Diagnostic microbiology and infectious disease
container_volume 110
creator Opperman, Christoffel
Johannes, Chaldene
Singh, Sarishna
Ghebrekristos, Yonas
Warren, Rob
Esmail, Aliasgar
Goosen, Wynand
description •Prevalence of nontuberculous mycobacteria (NTM) among a GXP-negative cohort was 1.7 %.•CMdirect line probe assay showed a specificity of 100 % as a possible rule-in test.•Culture-independent molecular techniques on decontaminated sputum could aid in NTM identification. The GenoType CMdirect Ver 1.0 and GenoType Mycobacterium Common Mycobacteria Ver 2.0-line probe assays were utilized to identify nontuberculous mycobacteria (NTM) from decontaminated sputum in a GeneXpert MTB/RIF Ultra negative cohort. A preliminary NTM prevalence of 1.7 % was observed, with a 100 % specificity. The high specificity advocates the CMdirect as a possible rule-in test for NTM disease.
doi_str_mv 10.1016/j.diagmicrobio.2024.116531
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3106732311</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0732889324003560</els_id><sourcerecordid>3106732311</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1689-95a375b7faf8aa61043981b5436e63699d136151e29be3149e6fa391fd6790243</originalsourceid><addsrcrecordid>eNqNkV1v0zAUhiMEYmXwF5DFFTfpfOLEiXdXOjYqrUKCTuLOcpKTzlXiFH9Uyh_kd-Eqg3HJlSXrOV_vkyQfgC6BAr86LFut9oNu7FjrcZnRLF8C8ILBi2QBVSlSSkv6MlnQkmVpVQl2kbxx7kApZCKnr5MLJjLBGIhF8mvTovG6043yejRk7IgZjQ812ib0Y3BkmJqxVo1HqxUJTps98Y9I7tCMu-mIZL1ttcXGE2Xa59_tc1UYIkN6bZAc48ZIlHNqckSbM44_jmg92e4-XX3b3JKH3ltFDO7jOick7hh8GK7Jinwfg38kq87GTU1shCfVo2ki4kM7vU1edap3-O7pvUwebj_v1l_S-693m_XqPm2AVyIVhWJlUZed6iqlONCciQrqImccOeNCtMA4FICZqJFBLpB3ignoWl6KGDO7TD7OfeMlPwM6LwftGux7ZTCGJRlQHkNnABG9ntGoyTmLnTxaPSg7SaDy7FEe5L8e5dmjnD3G4vdPc0I9YPu39I-4CNzMAMZrTxqtdI0-5zHLkO2o_2fOb7GiuEM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3106732311</pqid></control><display><type>article</type><title>Identification of nontuberculous mycobacteria using the GenoType CMdirect and GenoType Mycobacterium CM line probe assays in GeneXpert MTB/RIF Ultra negative sputum: A South African prevalence study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Opperman, Christoffel ; Johannes, Chaldene ; Singh, Sarishna ; Ghebrekristos, Yonas ; Warren, Rob ; Esmail, Aliasgar ; Goosen, Wynand</creator><creatorcontrib>Opperman, Christoffel ; Johannes, Chaldene ; Singh, Sarishna ; Ghebrekristos, Yonas ; Warren, Rob ; Esmail, Aliasgar ; Goosen, Wynand</creatorcontrib><description>•Prevalence of nontuberculous mycobacteria (NTM) among a GXP-negative cohort was 1.7 %.•CMdirect line probe assay showed a specificity of 100 % as a possible rule-in test.•Culture-independent molecular techniques on decontaminated sputum could aid in NTM identification. The GenoType CMdirect Ver 1.0 and GenoType Mycobacterium Common Mycobacteria Ver 2.0-line probe assays were utilized to identify nontuberculous mycobacteria (NTM) from decontaminated sputum in a GeneXpert MTB/RIF Ultra negative cohort. A preliminary NTM prevalence of 1.7 % was observed, with a 100 % specificity. The high specificity advocates the CMdirect as a possible rule-in test for NTM disease.</description><identifier>ISSN: 0732-8893</identifier><identifier>ISSN: 1879-0070</identifier><identifier>EISSN: 1879-0070</identifier><identifier>DOI: 10.1016/j.diagmicrobio.2024.116531</identifier><identifier>PMID: 39293319</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Genotype ; GenoType CMdirect ; GenoType Mycobacterium CM ; Humans ; Molecular assay ; Molecular Diagnostic Techniques - methods ; Mycobacterium Infections, Nontuberculous - diagnosis ; Mycobacterium Infections, Nontuberculous - epidemiology ; Mycobacterium Infections, Nontuberculous - microbiology ; Nontuberculous mycobacteria ; Nontuberculous Mycobacteria - classification ; Nontuberculous Mycobacteria - genetics ; Nontuberculous Mycobacteria - isolation &amp; purification ; Prevalence ; Sensitivity and Specificity ; South Africa ; South Africa - epidemiology ; Sputum ; Sputum - microbiology</subject><ispartof>Diagnostic microbiology and infectious disease, 2024-12, Vol.110 (4), p.116531, Article 116531</ispartof><rights>2024 Elsevier Inc.</rights><rights>Copyright © 2024 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1689-95a375b7faf8aa61043981b5436e63699d136151e29be3149e6fa391fd6790243</cites><orcidid>0000-0002-6676-5431</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0732889324003560$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39293319$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Opperman, Christoffel</creatorcontrib><creatorcontrib>Johannes, Chaldene</creatorcontrib><creatorcontrib>Singh, Sarishna</creatorcontrib><creatorcontrib>Ghebrekristos, Yonas</creatorcontrib><creatorcontrib>Warren, Rob</creatorcontrib><creatorcontrib>Esmail, Aliasgar</creatorcontrib><creatorcontrib>Goosen, Wynand</creatorcontrib><title>Identification of nontuberculous mycobacteria using the GenoType CMdirect and GenoType Mycobacterium CM line probe assays in GeneXpert MTB/RIF Ultra negative sputum: A South African prevalence study</title><title>Diagnostic microbiology and infectious disease</title><addtitle>Diagn Microbiol Infect Dis</addtitle><description>•Prevalence of nontuberculous mycobacteria (NTM) among a GXP-negative cohort was 1.7 %.•CMdirect line probe assay showed a specificity of 100 % as a possible rule-in test.•Culture-independent molecular techniques on decontaminated sputum could aid in NTM identification. The GenoType CMdirect Ver 1.0 and GenoType Mycobacterium Common Mycobacteria Ver 2.0-line probe assays were utilized to identify nontuberculous mycobacteria (NTM) from decontaminated sputum in a GeneXpert MTB/RIF Ultra negative cohort. A preliminary NTM prevalence of 1.7 % was observed, with a 100 % specificity. The high specificity advocates the CMdirect as a possible rule-in test for NTM disease.</description><subject>Genotype</subject><subject>GenoType CMdirect</subject><subject>GenoType Mycobacterium CM</subject><subject>Humans</subject><subject>Molecular assay</subject><subject>Molecular Diagnostic Techniques - methods</subject><subject>Mycobacterium Infections, Nontuberculous - diagnosis</subject><subject>Mycobacterium Infections, Nontuberculous - epidemiology</subject><subject>Mycobacterium Infections, Nontuberculous - microbiology</subject><subject>Nontuberculous mycobacteria</subject><subject>Nontuberculous Mycobacteria - classification</subject><subject>Nontuberculous Mycobacteria - genetics</subject><subject>Nontuberculous Mycobacteria - isolation &amp; purification</subject><subject>Prevalence</subject><subject>Sensitivity and Specificity</subject><subject>South Africa</subject><subject>South Africa - epidemiology</subject><subject>Sputum</subject><subject>Sputum - microbiology</subject><issn>0732-8893</issn><issn>1879-0070</issn><issn>1879-0070</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkV1v0zAUhiMEYmXwF5DFFTfpfOLEiXdXOjYqrUKCTuLOcpKTzlXiFH9Uyh_kd-Eqg3HJlSXrOV_vkyQfgC6BAr86LFut9oNu7FjrcZnRLF8C8ILBi2QBVSlSSkv6MlnQkmVpVQl2kbxx7kApZCKnr5MLJjLBGIhF8mvTovG6043yejRk7IgZjQ812ib0Y3BkmJqxVo1HqxUJTps98Y9I7tCMu-mIZL1ttcXGE2Xa59_tc1UYIkN6bZAc48ZIlHNqckSbM44_jmg92e4-XX3b3JKH3ltFDO7jOick7hh8GK7Jinwfg38kq87GTU1shCfVo2ki4kM7vU1edap3-O7pvUwebj_v1l_S-693m_XqPm2AVyIVhWJlUZed6iqlONCciQrqImccOeNCtMA4FICZqJFBLpB3ignoWl6KGDO7TD7OfeMlPwM6LwftGux7ZTCGJRlQHkNnABG9ntGoyTmLnTxaPSg7SaDy7FEe5L8e5dmjnD3G4vdPc0I9YPu39I-4CNzMAMZrTxqtdI0-5zHLkO2o_2fOb7GiuEM</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Opperman, Christoffel</creator><creator>Johannes, Chaldene</creator><creator>Singh, Sarishna</creator><creator>Ghebrekristos, Yonas</creator><creator>Warren, Rob</creator><creator>Esmail, Aliasgar</creator><creator>Goosen, Wynand</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6676-5431</orcidid></search><sort><creationdate>202412</creationdate><title>Identification of nontuberculous mycobacteria using the GenoType CMdirect and GenoType Mycobacterium CM line probe assays in GeneXpert MTB/RIF Ultra negative sputum: A South African prevalence study</title><author>Opperman, Christoffel ; Johannes, Chaldene ; Singh, Sarishna ; Ghebrekristos, Yonas ; Warren, Rob ; Esmail, Aliasgar ; Goosen, Wynand</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1689-95a375b7faf8aa61043981b5436e63699d136151e29be3149e6fa391fd6790243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Genotype</topic><topic>GenoType CMdirect</topic><topic>GenoType Mycobacterium CM</topic><topic>Humans</topic><topic>Molecular assay</topic><topic>Molecular Diagnostic Techniques - methods</topic><topic>Mycobacterium Infections, Nontuberculous - diagnosis</topic><topic>Mycobacterium Infections, Nontuberculous - epidemiology</topic><topic>Mycobacterium Infections, Nontuberculous - microbiology</topic><topic>Nontuberculous mycobacteria</topic><topic>Nontuberculous Mycobacteria - classification</topic><topic>Nontuberculous Mycobacteria - genetics</topic><topic>Nontuberculous Mycobacteria - isolation &amp; purification</topic><topic>Prevalence</topic><topic>Sensitivity and Specificity</topic><topic>South Africa</topic><topic>South Africa - epidemiology</topic><topic>Sputum</topic><topic>Sputum - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Opperman, Christoffel</creatorcontrib><creatorcontrib>Johannes, Chaldene</creatorcontrib><creatorcontrib>Singh, Sarishna</creatorcontrib><creatorcontrib>Ghebrekristos, Yonas</creatorcontrib><creatorcontrib>Warren, Rob</creatorcontrib><creatorcontrib>Esmail, Aliasgar</creatorcontrib><creatorcontrib>Goosen, Wynand</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diagnostic microbiology and infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Opperman, Christoffel</au><au>Johannes, Chaldene</au><au>Singh, Sarishna</au><au>Ghebrekristos, Yonas</au><au>Warren, Rob</au><au>Esmail, Aliasgar</au><au>Goosen, Wynand</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of nontuberculous mycobacteria using the GenoType CMdirect and GenoType Mycobacterium CM line probe assays in GeneXpert MTB/RIF Ultra negative sputum: A South African prevalence study</atitle><jtitle>Diagnostic microbiology and infectious disease</jtitle><addtitle>Diagn Microbiol Infect Dis</addtitle><date>2024-12</date><risdate>2024</risdate><volume>110</volume><issue>4</issue><spage>116531</spage><pages>116531-</pages><artnum>116531</artnum><issn>0732-8893</issn><issn>1879-0070</issn><eissn>1879-0070</eissn><abstract>•Prevalence of nontuberculous mycobacteria (NTM) among a GXP-negative cohort was 1.7 %.•CMdirect line probe assay showed a specificity of 100 % as a possible rule-in test.•Culture-independent molecular techniques on decontaminated sputum could aid in NTM identification. The GenoType CMdirect Ver 1.0 and GenoType Mycobacterium Common Mycobacteria Ver 2.0-line probe assays were utilized to identify nontuberculous mycobacteria (NTM) from decontaminated sputum in a GeneXpert MTB/RIF Ultra negative cohort. A preliminary NTM prevalence of 1.7 % was observed, with a 100 % specificity. The high specificity advocates the CMdirect as a possible rule-in test for NTM disease.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39293319</pmid><doi>10.1016/j.diagmicrobio.2024.116531</doi><orcidid>https://orcid.org/0000-0002-6676-5431</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0732-8893
ispartof Diagnostic microbiology and infectious disease, 2024-12, Vol.110 (4), p.116531, Article 116531
issn 0732-8893
1879-0070
1879-0070
language eng
recordid cdi_proquest_miscellaneous_3106732311
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Genotype
GenoType CMdirect
GenoType Mycobacterium CM
Humans
Molecular assay
Molecular Diagnostic Techniques - methods
Mycobacterium Infections, Nontuberculous - diagnosis
Mycobacterium Infections, Nontuberculous - epidemiology
Mycobacterium Infections, Nontuberculous - microbiology
Nontuberculous mycobacteria
Nontuberculous Mycobacteria - classification
Nontuberculous Mycobacteria - genetics
Nontuberculous Mycobacteria - isolation & purification
Prevalence
Sensitivity and Specificity
South Africa
South Africa - epidemiology
Sputum
Sputum - microbiology
title Identification of nontuberculous mycobacteria using the GenoType CMdirect and GenoType Mycobacterium CM line probe assays in GeneXpert MTB/RIF Ultra negative sputum: A South African prevalence study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A06%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20nontuberculous%20mycobacteria%20using%20the%20GenoType%20CMdirect%20and%20GenoType%20Mycobacterium%20CM%20line%20probe%20assays%20in%20GeneXpert%20MTB/RIF%20Ultra%20negative%20sputum:%20A%20South%20African%20prevalence%20study&rft.jtitle=Diagnostic%20microbiology%20and%20infectious%20disease&rft.au=Opperman,%20Christoffel&rft.date=2024-12&rft.volume=110&rft.issue=4&rft.spage=116531&rft.pages=116531-&rft.artnum=116531&rft.issn=0732-8893&rft.eissn=1879-0070&rft_id=info:doi/10.1016/j.diagmicrobio.2024.116531&rft_dat=%3Cproquest_cross%3E3106732311%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3106732311&rft_id=info:pmid/39293319&rft_els_id=S0732889324003560&rfr_iscdi=true